Adaptive clinical trial designs for phase I cancer studies (Q2452091): Difference between revisions
From MaRDI portal
Changed an Item |
Changed an Item |
||
| Property / describes a project that uses | |||
| Property / describes a project that uses: np1 / rank | |||
Normal rank | |||
Revision as of 07:54, 28 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adaptive clinical trial designs for phase I cancer studies |
scientific article |
Statements
Adaptive clinical trial designs for phase I cancer studies (English)
0 references
30 May 2014
0 references
Bayesian designs
0 references
``best intention'' designs
0 references
continual reassessment method
0 references
dose finding studies
0 references
estimation efficiency
0 references
ethics
0 references
maximum tolerated dose
0 references
oncology trial designs
0 references
optimal designs
0 references
phase I
0 references
stochastic approximation
0 references
toxicity
0 references
up-and-down designs
0 references
